What does this research mean for the field?

Hyperpolarized [1-13C]pyruvate MRI provides noninvasive metabolic characterization of focal liver lesions, and alanine-indexed metrics serve as biomarkers for progression to hepatocellular carcinoma beyond standard CT/MRI categorization. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

To evaluate the feasibility of hyperpolarized [1-13C]pyruvate MRI for noninvasive metabolic characterization of focal liver lesions in individuals with hepatocellular carcinoma.

August 30, 2026Radiology Imaging CancerOpen Access

Proof-of-Concept Study of Hyperpolarized [1- 13 C]Pyruvate MRI in Participants with Hepatocellular Carcinoma

View Full Paper

Ask AI

Bookmark

To evaluate the feasibility of hyperpolarized [1-13C]pyruvate MRI for noninvasive metabolic characterization of focal liver lesions in individuals with hepatocellular carcinoma.
Conducted a proof-of-concept imaging study utilizing hyperpolarized [1-13C]pyruvate MRI in participants with focal liver lesions.
Assessed metabolic profiles and alanine-indexed imaging metrics in comparison to conventional CT/MRI Liver Imaging Reporting and Data System (LI-RADS) categories.
Hyperpolarized [1-13C]pyruvate MRI successfully achieved noninvasive metabolic characterization of focal liver lesions.
Alanine-indexed metabolic metrics identified biological markers of progression to hepatocellular carcinoma beyond standard LI-RADS categorization.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Proof-of-concept study demonstrates noninvasive metabolic characterization of focal liver lesions, indicating alanine-indexed MRI metrics track progression to hepatocellular carcinoma.

Cite This Study

Kjærgaard et al. (2026) studied this question.

synapsesocial.com/papers/6a93f0b06c1a8fb52e79cfd5 https://doi.org/10.1148/rycan.250784

View Full Paper

Ask AI

Bookmark

Implication

Proof-of-concept study demonstrates noninvasive metabolic characterization of focal liver lesions, indicating alanine-indexed MRI metrics track progression to hepatocellular carcinoma.

Proof-of-Concept Study of Hyperpolarized [1- 13 C]Pyruvate MRI in Participants with Hepatocellular Carcinoma

Key Points

Discussion

Implication

Cite This Study

Proof-of-Concept Study of Hyperpolarized [1- 13 C]Pyruvate MRI in Participants with Hepatocellular Carcinoma

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider